Brief: Sigilon Therapeutics Reports Second Quarter 2022 Financial Results And Business Highlights
04/08/2022 22:40
Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON
STOCKHOLDERS-BASIC AND DILUTED $0.44
* Q2 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1DD7wd
Further company coverage: SGTX.O
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx